|
US5853719A
(en)
*
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
CN1254376A
(zh)
*
|
1996-10-01 |
2000-05-24 |
杰龙公司 |
端粒酶逆转录酶
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
WO1999050392A1
(en)
|
1998-03-31 |
1999-10-07 |
Geron Corporation |
Methods and compositions for eliciting an immune response to a telomerase antigen
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
US20020192681A1
(en)
*
|
2000-10-24 |
2002-12-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
EP1363931A4
(en)
*
|
2001-02-01 |
2004-04-07 |
Tanox Inc |
METHOD FOR THE PRODUCTION AND IDENTIFICATION OF MONOCLONAL ANTIBODIES AGAINST A LARGE NUMBER OF HUMAN ANTIGENS
|
|
DE10112851C1
(de)
*
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
CN1541113A
(zh)
*
|
2001-04-27 |
2004-10-27 |
�Ƹ��� |
利用激活的t细胞使抗原提呈细胞成熟
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
EP1903054A3
(de)
|
2001-06-05 |
2008-07-23 |
CureVac GmbH |
Stabilisierte mRNA mit erhöhtem G/C-Gehalt und optimierter Codon Usage für die Gentherapie
|
|
US7045335B2
(en)
*
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
JP2005526001A
(ja)
*
|
2001-10-04 |
2005-09-02 |
アグイラルーコルドバ，カリオス，エスツアルド |
遺伝子療法用キメラ型ウイルスベクター
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CA2491574A1
(en)
*
|
2002-07-05 |
2004-01-15 |
Duke University |
Angio-immunotherapy
|
|
US20040161417A1
(en)
*
|
2002-08-14 |
2004-08-19 |
Eli Gilboa |
Method of enhancing CD4+ T cell responses
|
|
DK2261249T3
(en)
|
2002-09-12 |
2015-02-16 |
Oncotherapy Science Inc |
KDR peptides and vaccines comprising the same
|
|
WO2004053095A2
(en)
*
|
2002-12-10 |
2004-06-24 |
Merix Bioscience, Inc. |
In situ maturation of dendritic cells
|
|
EP1585812B1
(en)
|
2002-12-13 |
2017-01-18 |
Alphavax, Inc. |
Multi-antigenic alphavirus replicon particles and methods
|
|
JP5079981B2
(ja)
*
|
2002-12-13 |
2012-11-21 |
アルファバックス，インコーポレイティド |
アルファウイルス粒子及び調製方法
|
|
WO2004073641A2
(en)
|
2003-02-18 |
2004-09-02 |
Kevin Slawin |
Induced activation in dendritic cells
|
|
EP1597390A4
(en)
*
|
2003-02-18 |
2006-12-27 |
Maxcyte Inc |
LOADING CELLS WITH ANTIGENES BY ELECTROPORATION
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
KR101518309B1
(ko)
*
|
2003-03-20 |
2015-05-08 |
알파벡스, 인크. |
개선된 알파바이러스 레플리콘 및 헬퍼 구축물
|
|
EP1651666B1
(en)
*
|
2003-07-11 |
2009-05-27 |
Alphavax, Inc. |
Alphavirus-based cytomegalovirus vaccines
|
|
DE10335833A1
(de)
*
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
CN1882603A
(zh)
*
|
2003-11-25 |
2006-12-20 |
阿哥斯医疗公司 |
mRNA转染的抗原呈递细胞
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
WO2005084387A2
(en)
*
|
2004-03-02 |
2005-09-15 |
Tsuneya Ohno |
Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
|
|
ES2321212T3
(es)
|
2004-05-18 |
2009-06-03 |
Alphavax, Inc. |
Vectores alfavirus derivados de tc-83, particulas y metodos antecentes de la invencion.
|
|
US20080293581A1
(en)
*
|
2004-05-24 |
2008-11-27 |
Rogler Charles E |
Rna Expression Microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
AU2005284922B2
(en)
*
|
2004-09-14 |
2010-12-23 |
Coimmune, Inc. |
Strain independent amplification of pathogens and vaccines thereto
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
PL2325306T3
(pl)
|
2005-02-25 |
2014-07-31 |
Oncotherapy Science Inc |
Szczepionki peptydowe do zastosowania w nowotworach płuc, wykazujących ekspresję polipeptydów TTK, URLC10 lub KOC1
|
|
EP1855707B1
(en)
|
2005-02-28 |
2012-04-04 |
Oncotherapy Science, Inc. |
Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
|
|
KR20150032915A
(ko)
|
2005-04-08 |
2015-03-30 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
|
RU2526196C2
(ru)
|
2005-07-27 |
2014-08-20 |
Онкотерапи Сайенс, Инк. |
Связанный с раком толстого кишечника ген том34
|
|
CA2626238C
(en)
|
2005-10-17 |
2015-10-06 |
Memorial Sloan Kettering Cancer Center |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
US9265816B2
(en)
|
2006-04-10 |
2016-02-23 |
Sloan Kettering Institute For Cancer Research |
Immunogenic WT-1 peptides and methods of use thereof
|
|
WO2007120863A2
(en)
|
2006-04-14 |
2007-10-25 |
Epicentre Technologies |
Kits and methods for generating 5' capped rna
|
|
CN101484461B
(zh)
|
2006-08-18 |
2014-09-17 |
阿哥斯医疗公司 |
Cd83在联合治疗中的用途
|
|
EP2687540A1
(en)
|
2006-10-17 |
2014-01-22 |
Oncotherapy Science, Inc. |
Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
|
|
EP2465510B1
(en)
*
|
2006-10-19 |
2018-11-28 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI615403B
(zh)
|
2007-02-21 |
2018-02-21 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
DK2183368T3
(en)
|
2007-06-21 |
2016-09-05 |
Alphavax Inc |
PROMOTER-FREE CASES FOR EXPRESSION OF ALPHAVIRUS STRUCTURE PROTEINS
|
|
MX2010002002A
(es)
|
2007-08-20 |
2010-03-11 |
Oncotherapy Science Inc |
Peptido foxm1 y agente medicinal que lo contiene.
|
|
WO2009108341A1
(en)
|
2008-02-28 |
2009-09-03 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
DK3156069T3
(da)
|
2008-06-20 |
2020-09-21 |
Univ Duke |
Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons
|
|
CA2738031C
(en)
*
|
2008-09-22 |
2022-11-29 |
Baylor College Of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
|
CN102272153B
(zh)
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
|
TWI500932B
(zh)
|
2008-12-05 |
2015-09-21 |
Oncotherapy Science Inc |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US9841426B2
(en)
*
|
2009-03-11 |
2017-12-12 |
Marker Gene Technologies, Inc |
Intracellular organelle peptide targeted enzyme substrates
|
|
SG2014013148A
(en)
|
2009-03-18 |
2014-07-30 |
Oncotherapy Science Inc |
Neil3 peptides and vaccines including the same
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
JP5838482B2
(ja)
|
2010-03-11 |
2016-01-06 |
オンコセラピー・サイエンス株式会社 |
Ｈｊｕｒｐペプチドおよびそれを含むワクチン
|
|
TW201627003A
(zh)
|
2010-04-02 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
KR102015648B1
(ko)
|
2011-08-12 |
2019-08-28 |
온코세라피 사이언스 가부시키가이샤 |
Ｍｐｈｏｓｐｈ１ 펩티드 및 이를 포함한 백신
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
CA3122778A1
(en)
|
2011-10-28 |
2013-05-02 |
Oncotherapy Science, Inc. |
Topk peptides and vaccines including the same
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
CA2861206C
(en)
|
2012-01-13 |
2021-07-06 |
Richard J. O'reilly |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9561265B2
(en)
|
2012-07-10 |
2017-02-07 |
Oncotherapy Science, Inc. |
KIF20A epitope peptides for TH1 cells and vaccines containing the same
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
CN110078813B
(zh)
|
2013-01-15 |
2023-03-28 |
纪念斯隆凯特林癌症中心 |
免疫原性wt-1肽和其使用方法
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
EP2968502B1
(en)
|
2013-03-14 |
2020-08-26 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
CA2912172A1
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
WO2015047901A1
(en)
|
2013-09-24 |
2015-04-02 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
US10934346B2
(en)
|
2014-02-14 |
2021-03-02 |
Bellicum Pharmaceuticals, Inc. |
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
|
|
US12214038B2
(en)
*
|
2014-07-22 |
2025-02-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
CN113321704B
(zh)
|
2014-08-04 |
2026-05-12 |
肿瘤疗法科学股份有限公司 |
Cdca1衍生的肽和含有它们的疫苗
|
|
EP4353321A3
(en)
|
2014-08-04 |
2024-07-10 |
OncoTherapy Science, Inc. |
Koc1-derived peptide and vaccine including same
|
|
RU2700881C2
(ru)
|
2014-08-04 |
2019-09-23 |
Онкотерапи Сайенс, Инк. |
Пептид, полученный из urlc10, и содержащая его вакцина
|
|
CA2959168A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
|
US10987412B2
(en)
*
|
2014-09-17 |
2021-04-27 |
The John Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cells
|
|
MX389823B
(es)
|
2014-10-27 |
2025-03-20 |
Fred Hutchinson Cancer Center |
Composiciones y metodos para reforzar la eficacia de inmunoterapia celular adoptiva.
|
|
EP3215522B1
(en)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
JP6873482B2
(ja)
|
2015-10-08 |
2021-05-19 |
オンコセラピー・サイエンス株式会社 |
Ｆｏｘｍ１由来ペプチドおよびそれを含むワクチン
|
|
WO2017134265A1
(en)
|
2016-02-05 |
2017-08-10 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
US11723962B2
(en)
|
2016-05-04 |
2023-08-15 |
Fred Hutchinson Cancer Center |
Cell-based neoantigen vaccines and uses thereof
|
|
US11331343B2
(en)
|
2016-06-29 |
2022-05-17 |
Duke University |
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
|
|
CN111818940A
(zh)
*
|
2018-01-05 |
2020-10-23 |
安德烈亚斯·罗尔夫-乔纳斯·尼尔森 |
用作疫苗的内源性肿瘤衍生的环状rna及其蛋白质
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
AU2024377914A1
(en)
*
|
2023-11-06 |
2026-04-09 |
Immunitybio, Inc. |
Virally educated t cells
|